FDA Lacks Legal Sway To Enforce AER Label Revisions – Attorney
This article was originally published in The Tan Sheet
Executive Summary
There is little chance FDA will aggressively enforce changes to dietary supplement and OTC drug labels recommended in the adverse event report labeling guidance, a food and drug attorney says